Sun Pharmaceutical is an Indian specialty pharmaceutical company. Its portfolio includes the production of the following products: generics, branded generics, specialty, complex or technology-heavy products, over-the-counter (OTC), antiretroviral (ARV), active pharmaceutical ingredients (API) and intermediates and various dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams and fluids.
Sun Pharma's main markets are India and the United States.
In 2015, Sun Pharma acquired another large Indian pharmaceutical company, Ranbaxy.
The main therapeutic areas in which the company operates are psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology.
Translated with www.DeepL.com/Translator (free version)